EntryPoint Capital, LLC
- SEC CIK
- 0001992519
- Latest filing
- Aug 13, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,527−100.0% | Sold out | Holders |
| Q4 2025 | 1,527 | $607.2K | 0.2% | +469+44.3% | Added | Holders |
| Q3 2025 | 1,058 | $482.4K | 0.2% | −492−31.7% | Reduced | Holders |
| Q2 2025 | 1,550 | $505.4K | 0.3% | −814−34.4% | Reduced | Holders |
| Q1 2025 | 2,364 | $638.3K | 0.3% | −178−7.0% | Reduced | Holders |
| Q4 2024 | 2,542 | $598.2K | 0.3% | +948+59.5% | Added | Holders |
| Q3 2024 | 1,594 | $438.4K | 0.2% | +575+56.4% | Added | Holders |
| Q2 2024 | 1,019 | $247.6K | 0.1% | −705−40.9% | Reduced | Holders |
| Q1 2024 | 1,724 | $257.7K | 0.2% | +711+70.2% | Added | Holders |
| Q4 2023 | 1,013 | $193.9K | 0.2% | – | No prior filing | Holders |